Coinfection with HIV and hepatitis C virus in injection drug users and minority populations.
about
Underlying Pathophysiology of HCV Infection in HIV-Positive Drug UsersHIV-, HCV-, and co-infections and associated risk factors among drug users in southwestern China: a township-level ecological study incorporating spatial regressionTreatment optimization for HIV/HCV co-infected patients.Infectious disease comorbidities adversely affecting substance users with HIV: hepatitis C and tuberculosis.Injection and non-injection drug use and infectious disease in Baltimore City: differences by race.National trends in hospitalization and mortality rates for patients with HIV, HCV, or HIV/HCV coinfection from 1996-2010 in the United States: a cross-sectional studyFelt and enacted stigma among HIV/HCV-coinfected adults: the impact of stigma layeringThe geographic distribution patterns of HIV-, HCV- and co-infections among drug users in a national methadone maintenance treatment program in Southwest China.Cystatin C and creatinine in an HIV cohort: the nutrition for healthy living study.Awareness of hepatitis C infection among women with and at risk for HIV.Injecting drug use is associated with HIV risk perception among Mexican Americans in the Rio Grande Valley of South Texas, USA.Drug abuse and hepatitis C infection as comorbid features of HIV associated neurocognitive disorder: neurocognitive and neuroimaging featuresEffect of HIV on liver fibrosis among HCV-infected African AmericansImpact of HCV treatment and depressive symptoms on adherence to HAART among HIV-HCV-coinfected patients: results from the ANRS-CO13-HEPAVIH cohort.Hepatic fibrosis and immune phenotype vary by HCV viremia in HCV/HIV co-infected subjects: A Women's interagency HIV study.Recommendations for the management of hepatitis C virus infection among people who inject drugs.Hepatitis C virus treatment as prevention in an extended network of people who inject drugs in the USA: a modelling study.The risk of hepatocellular carcinoma in patients with previous malignancy.The natural history of injecting drug use: a 25-year longitudinal study of a cohort of injecting drug users in inner city Dublin.HCV/HIV coinfection among people who inject drugs and enter opioid substitution treatment in Greece: prevalence and correlates
P2860
Q27489073-5D0F44DB-B347-4331-9D65-C23F7CA3FEDFQ28541708-C183199B-C92D-4D91-864A-3C22278EDF05Q30235034-00D789D7-31AE-46F4-AD94-DB96178ED0ADQ30395708-E5BB4BB0-9522-4365-A41C-D1448428BA3DQ33833340-6E6A98BA-39EF-4934-8133-AFBB516241BCQ34873781-38531221-DAE4-40F9-B136-1FDCF72937F3Q35068953-E945A7BE-6F2D-4396-AD36-9E298E7F1E8DQ35115722-EB73B1C3-0C2D-4CE7-80D8-196E4444B266Q35604023-D02ADDDE-52AD-4735-BF12-C45CCF6B22B4Q36416942-0E4EED37-99E8-470A-B3A4-BA42E34B56AAQ36498633-4554B3AE-1652-402B-A75A-4D64F59390E2Q36792636-89141BE3-C1D7-4DD6-8AB8-3AFA25578144Q36853890-C3C0A7DD-7197-4783-B06E-BC74FC369093Q37410198-EB4432CB-1C51-4FC1-963E-50EC37143CF4Q37726687-5CDD993C-BB0B-41FF-B725-BD4BF1FAB0FFQ42280296-3113520C-7E01-41F9-97A7-F93BDACD9F01Q45324640-E1909CFB-EA80-426D-A9BB-1DDF7820D66BQ46528075-1034E6F6-E3C8-4880-9192-32BDE397E6A2Q46560463-9EA89B87-A01A-4A7A-AFF5-A8604337DC80Q57709954-FC9011D3-922E-44B9-A2E0-AAB5E31F7507
P2860
Coinfection with HIV and hepatitis C virus in injection drug users and minority populations.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年学术文章
@wuu
2005年学术文章
@zh-cn
2005年学术文章
@zh-hans
2005年学术文章
@zh-my
2005年学术文章
@zh-sg
2005年學術文章
@yue
2005年學術文章
@zh
2005年學術文章
@zh-hant
name
Coinfection with HIV and hepat ...... sers and minority populations.
@ast
Coinfection with HIV and hepat ...... sers and minority populations.
@en
type
label
Coinfection with HIV and hepat ...... sers and minority populations.
@ast
Coinfection with HIV and hepat ...... sers and minority populations.
@en
prefLabel
Coinfection with HIV and hepat ...... sers and minority populations.
@ast
Coinfection with HIV and hepat ...... sers and minority populations.
@en
P2860
P356
P1476
Coinfection with HIV and hepat ...... sers and minority populations.
@en
P2093
Doris B Strader
P2860
P356
10.1086/429489
P407
P478
41 Suppl 1
P577
2005-07-01T00:00:00Z